Selective Modulation of α5 GABAA Receptors Exacerbates Aberrant Inhibition at Key Hippocampal Neuronal Circuits in APP Mouse Model of Alzheimer’s Disease. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.